Ardelyx, Inc.
ARDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001437402
In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Ardelyx, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- −18 vs. Q2 2021
- Shares held
- 49.0M
- −35.5M (−42.0%) vs. Q2 2021
- Total value
- $66.7M
- −$573.5M (−89.6%) vs. Q2 2021
- New holders
- 21
- 37 more added
- Sold out
- 39
- 29 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 250 | $906.4M |
| Q1 2026 | 242 | $1.01B |
| Q4 2025 | 229 | $972.9M |
| Q3 2025 | 223 | $891.4M |
| Q2 2025 | 206 | $657.3M |
| Q1 2025 | 221 | $808.7M |
| Q4 2024 | 213 | $765.2M |
| Q3 2024 | 203 | $982.8M |
| Q2 2024 | 197 | $1.07B |
| Q1 2024 | 189 | $1.03B |
| Q4 2023 | 161 | $849.0M |
| Q3 2023 | 150 | $513.5M |
| Q2 2023 | 146 | $426.0M |
| Q1 2023 | 130 | $550.1M |
| Q4 2022 | 104 | $225.7M |
| Q3 2022 | 83 | $79.6M |
| Q2 2022 | 78 | $22.7M |
| Q1 2022 | 89 | $42.4M |
| Q4 2021 | 100 | $46.0M |
| Q3 2021 | 108 | $66.7M |
| Q2 2021 | 127 | $643.2M |
| Q1 2021 | 125 | $559.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Ardelyx, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Orchard Capital Managment, LLC | 1,274,280 | $1.68M | 0.51% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 282,978 | $2.12M | 0.00% | −167,982−37.2% | Reduced |
| Geode Capital Management, LLC | 1,768,308 | $2.33M | 0.00% | +323,910+22.4% | Added |
| State Street Corp | 2,017,648 | $2.66M | 0.00% | −4,263,149−67.9% | Reduced |
| Morgan Stanley | 2,280,023 | $3.01M | 0.00% | +2,082,527+1,054.5% | Added |
| Vanguard Group Inc | 3,963,547 | $5.23M | 0.00% | +66,954+1.7% | Added |
| BlackRock Inc. | 6,455,902 | $8.52M | 0.00% | +237,006+3.8% | Added |
| NEA Management Company, LLC | 13,633,582 | $18.0M | 0.23% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −6,077,294−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −5,248,829−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −3,811,554−100.0% | Sold out |
| Redmile Group, LLC | 0 | $0 | 0.00% | −3,714,100−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −3,348,363−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −2,385,162−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −2,019,859−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −1,915,942−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −851,291−100.0% | Sold out |
| Mangrove Partners | 0 | $0 | 0.00% | −638,050−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −582,867−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −325,233−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −279,355−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −269,000−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Brandywine Global Investment Management, LLC | 0 | $0 | 0.00% | −152,156−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −148,120−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −99,237−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −97,094−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −78,000−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −38,474−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −38,119−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −32,596−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −31,096−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −28,515−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −26,152−100.0% | Sold out |
| Oxinas Partners Wealth Management LLC | 0 | $0 | 0.00% | −18,280−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −15,900−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −11,120−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −10,773−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −36,396−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1,076−100.0% | Sold out |
| Berman Capital Advisors, LLC | 0 | $0 | 0.00% | −394−100.0% | Sold out |
| Reilly Financial Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |